The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of COVID-19 pandemic on time to treatment initiation for patients with advanced cancer.
 
Samuel U Takvorian
Stock and Other Ownership Interests - Bluebird Bio (I); Gilead Sciences (I); Johnson & Johnson (I); Merck (I); Novartis (I); Pfizer (I); Pfizer (I); Portola Pharmaceuticals (I)
Consulting or Advisory Role - Boehringer Ingelheim (I); Health Advances; Novartis (I); Novocure (I)
Research Funding - AstraZeneca (I); Lilly (I); Pfizer; Trizell (I)
 
Ravi Bharat Parikh
Stock and Other Ownership Interests - GNS Healthcare; Google; Merck
Consulting or Advisory Role - Cancer Study Group; GNS Healthcare; Onc.AI
Travel, Accommodations, Expenses - Conquer Cancer Foundation; Flatiron Health
 
Daniel Vader
Research Funding - Pfizer (Inst)
 
E. Paul Wileyto
No Relationships to Disclose
 
Amy Sanders Clark
Consulting or Advisory Role - Novartis
Research Funding - Novartis (Inst); Seagen
 
Daniel J. Lee
No Relationships to Disclose
 
Gaurav Goyal
No Relationships to Disclose
 
Gabrielle Betty Rocque
Consulting or Advisory Role - Pfizer
Research Funding - Carevive Systems; Genentech; Pfizer
Travel, Accommodations, Expenses - Carevive (I)
 
Efrat Dotan
Honoraria - Boston Biomedical; Pfizer
Consulting or Advisory Role - ARMO BioSciences
Research Funding - AstraZeneca (Inst); Bayer (Inst); Boston Biomedical (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Lilly (Inst); MedImmune (Inst); Merck (Inst); Pfizer (Inst)
 
Daniel M. Geynisman
Employment - 2nd.MD
Consulting or Advisory Role - AstraZeneca; Eisai; Exelixis; Merck; Myovant Sciences; Pfizer; Seattle Genetics/Astellas
Research Funding - Astellas Pharma (Inst); Calithera Biosciences (Inst); Genentech (Inst); Merck (Inst)
 
Pooja Phull
No Relationships to Disclose
 
Philippe E. Spiess
Leadership - Global Society of Rare Genitourinary Tumors; NCCN
Honoraria - UptoDate
Other Relationship - NCCN
(OPTIONAL) Uncompensated Relationships - Moffitt Cancer Center
 
Roger Kim
No Relationships to Disclose
 
Amy J. Davidoff
Honoraria - Celgene (I)
Consulting or Advisory Role - Abbvie (I); Amgen
Research Funding - Celgene (Inst)
(OPTIONAL) Uncompensated Relationships - Flatiron Health; Genentech/Roche; Genentech/Roche
 
Cary Philip Gross
Research Funding - AstraZeneca (Inst); Genentech; Johnson & Johnson (Inst); Pfizer (Inst)
(OPTIONAL) Uncompensated Relationships - Genentech (Inst)
 
Rebecca A. Miksad
Employment - Flatiron Health
Stock and Other Ownership Interests - Flatiron Health; Roche
Consulting or Advisory Role - Grand Rounds (I)
Other Relationship - De Luca Foundation
 
Gregory Sampang Calip
Employment - Flatiron Health
Research Funding - Pfizer (Inst)
 
Lawrence N. Shulman
Research Funding - Celgene
 
Ronac Mamtani
Honoraria - Flatiron Health
Consulting or Advisory Role - Genentech/Roche; Seattle Genetics/Astellas
Research Funding - Merck
 
Rebecca A. Hubbard
Research Funding - Humana (Inst); Merck (Inst); Pfizer (Inst)
(OPTIONAL) Uncompensated Relationships - Genentech